Aytekin Akyol

• G Guner, A Isik, E Karabulut, G Gedikoglu, C Sokmensuer, A Akyol. "Morphologic and Immunohistochemical Appraisal of Primary Gastric Carcinomas". Appl Immunohistochem Mol Morphol. doi: 10.1097/PAI.0000000000000618. [Epub ahead of print], 2018.
• Ö Saatci, S Borgoni, Ö Akbulut, S Durmuş, U Raza, E Eyüpoğlu, C Alkan, A Akyol, Ö Kütük, S Wiemann, Ö Şahin. "Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer" Oncogene. doi: 10.1038/s41388-017-0108-9. [Epub ahead of print] 2018.
• A Sağlam, A Usubütün, A Dolgun, GL Mutter, MC Salman, O Kurtulan, A Akyol, EA Özkan, S Baykara, D Bülbül, Z Calay, F Eren, D Gümürdülü, N Haberal, Ş Ilvan, Ş Karaveli, M Koyuncuoğlu, B Müezzinoğlu, KH Müftüoğlu, Ö Özen, N Özdemir, E Peştereli, Ç Ulukuş, O Zekioğlu. "Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis" Turk Patoloji Derg. 2017;1(1):177-191. doi: 10.5146/tjpath.2017.01400. 2017.
• G Guner, O Kurtulan, T Kav, C Sokmensuer, G Gedikoglu, A. Akyol. "Cyanoacrylate Associated Foreign Body Granulomatous Gastritis: A Report of Three Cases", Case Rep Pathol. 2017:2753487. doi: 10.1155/2017/2753487. 2017.
• O. Ozturk, Y. Bayraktar, A. Akyol. "A Neuroendocrine Tumor Invading All Portal Venous System Components", Am J Gastroenterol (SCI). Mar;111(3):311. doi: 10.1038/ajg.2015.308. 2016.
• Y. Feng, N. Sakamoto, R. Wu, J.Y. Liu, A. Wiese, M.E. Green, M. Green, A. Akyol, B.C. Roy, Y. Zhai, K.R. Cho, E.R. Fearon. "Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium", PLoS Genet. (SCI) 2015 Nov 3;11(11):e1005638. doi: 10.1371/journal.pgen.1005638. eCollection 2015.
• A. Koni, H.S. Ozseker, E. Arpali, E. Kilinc E, H.S. Dogan, A. Akyol, S. Tekgul. "Histopathological Evaluation of Orchiectomy Specimens in 51 Late Postpubertal Men with Unilateral Cryptorchidism", Journal of Urology (SCI), Cilt: 192(4):1183-8, pii: S0022-5347(14)03577-0. doi: 10.1016/j.juro.2014.05.048. [Epub ahead of print], 2014.

Alparslan Alp

• Koydemir HC, Külah H, Member, Alp A, Üner AH, Hasçelik G, and Özgen C. A fully microfabricated electrochemical sensor and its implementation for detection of methicillin resistance in Staphylococcus aureus. IEEE Sensors Journal 2014, 14 (6): 1844-1851.
• Cinel G, Pekcan S, Ozcelik U, Alp A, Yalcin E, Ersöz DD, Kiper N. Cytomegalovirus infection in immunocompetent wheezy infants: the diagnostic value of CMV PCR in bronchoalveolar lavage fluid. J Clin Pharmacy Therapeutics 2014; 39:399-403.
• Coban AY, Akbal AU, Bicmen C, Albay A, Sig AK, Uzun M, Selale DS, Ozkutuk N, Surucuoglu S, Albayrak N, Ucarman N, Ozkutuk A, Esen N, Ceyhan I, Ozyurt M, Bektore B, Aslan G, Delialioğlu N  & Alp A. Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Scientific Reports 2016, 6:39050; DOI: 10.1038/srep39050.
• Rifat D, Campodonico VL, Tao J, Miller JA, Alp A, Yao Y, Karakousis PC. In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D. Future Microbiol 2017, https://doi.org/10.2217/fmb-2017-0022.
• Sezen F, Albayrak N, Özkara Ş, Karagöz A, Alp A, Ağca FD, Süer Aİ, Müderris T, Ceyhan İ, Durmaz R, Ertek M, Tüberküloz Laboratuvar Sürveyans Ağı (TuLSA) Çalışma Grubu. Ulusal Tüberküloz Laboratuvar Sürveyansına İlk Adım; Ankara, 2011. Mikrobiyol Bült 2015; 49(2): 143-155.
• Çoban AY, Taştekin B, Uzun M, Kalayci F, Ceyhan İ, Biçmen C, Albay A, Siğ AK, Özkütük N, Sürücüoglu S, Özkütük A, Esen N, Albayrak N, Aslantürk A, Saribaş Z, Alp A. Çok İlaca Dirençli Tüberkülozun Hızlı Tespiti İçin Dolaylı Nitrat Redüktaz Testinin Çok Merkezli Değerlendirilmesi. Mikrobiyol Bul 2016; 50 (1): 140-146. doi: 10.5578/mb.10339.

Seçil Demirkol Canlı

• Demirkol S, Gomceli I, Isbilen M, Dayanc BE, Tez M, Bostanci EB, Turhan N, Akoglu M, Ozyerli E, Durdu S, Konu O, Nissan A, Gonen M, Gure AO. A (2017) Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer. J Cancer. 8(7):1113-1122. doi:10.7150/jca.17872
• Taskoparan B., Seza E.G., Demirkol S., Tuncer S., Stefek M., Gure AO, Banerjee S. (2017) Opposing roles of the aldo-keto reducatases AKR1B1 and AKR1B10 in colorectal cancer. Cellular Oncology.  2211-3428 .https://doi.org/10.1007/s13402-017-0351-7

Ömer Dizdar

• Guner G, Dizdar O. Glucocorticoids in breast cancer treatment: real benefit or selection bias? Breast Cancer Res Treat. 2018 Jul 26. doi: 10.1007/s10549-018-4871 [Epub ahead of print] PubMed PMID: 30051206.
• Akin S, Dizdar O, Karakas Y, Turker A, Kars A. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma. Curr Probl Cancer. 2018 May - Jun;42(3):344-349. doi: 10.1016/j.currproblcancer.2018.01.011. Epub 2018 Jan 31.  PubMed PMID: 29576383.
• Bilgin E, Erden A, Dizdar Ö. Familial Mediterranean Fever: New Insights Into Cancer Immunoprevention? Comment on the Article by Brenner et al. Arthritis Rheumatol. 2018 Jul;70(7):1167. doi: 10.1002/art.40497. Epub 2018 May 14. PubMed  PMID: 29569856.
• Ates O, Aksoy S, Yeter H, Sunar V, Kertmen N, Dizdar O, Turker A, Kars A. Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience. Indian J Cancer. 2017 Jan-Mar;54(1):321-325. doi: 10.4103/ijc.IJC_169_17. PubMed PMID: 29199714.
• Karakas Y, Dizdar O, Aksoy S, Hayran M, Altundag K. The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival. Clin Breast Cancer. 2018 Aug;18(4):320-327. doi: 10.1016/j.clbc.2017.11.002. Epub 2017 Nov 9. PubMed PMID: 29183716.
• Akin S, Dizdar Ö, Hayran M. Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms. Ann Surg Oncol. 2017 Dec;24(Suppl 3):620. doi: 10.1245/s10434-017-6147-1. Epub 2017 Nov 22. PubMed PMID: 29168096.
• Güven DC, Dizdar O. Fusobacterium and colorectal carcinogenesis. Carcinogenesis. 2018 Jan 12;39(1):84. doi: 10.1093/carcin/bgx092. PubMed PMID: 28968715.
• Dizdar O, Hayran M, Guven DC, Yılmaz TB, Taheri S, Akman AC, Bilgin E, Hüseyin B, Berker E. Increased cancer risk in patients with periodontitis. Curr Med Res Opin. 2017 Dec;33(12):2195-2200. doi: 10.1080/03007995.2017.1354829. Epub 2017 Aug 11. PubMed PMID: 28699803.
• Dizdar O, Bilgin E, Akin S, Kilickap S, Hayran M. Evaluation of complementary and alternative medicine trials registered in clinicaltrials.gov database. J BUON. 2017 Mar-Apr;22(2):530-534. PubMed PMID: 28534381.
• Karakas Y, Dizdar O. Tumor Sidedness and Prognosis in Colorectal Cancer: Is Microbiome the Missing Link? JAMA Oncol. 2017 Jul 1;3(7):1000. doi: 10.1001/jamaoncol.2017.0034. PubMed PMID: 28418502.
• Dizdar O, Akin S, Hayran M. Interpretation of survival data: which graphical analysis is appropriate? Ther Adv Med Oncol. 2016 Jul;8(4):312. doi: 10.1177/1758834016644870. Epub 2016 May 22. PubMed PMID: 27482291; PubMed Central PMCID: PMC4952022.
• Karakas Y, Akin S, Dizdar O, Aksoy S. Analysis of the Adjuvant Hormone Therapy Randomized Trial. J Clin Oncol. 2016 Jun 10;34(17):2070. doi: 10.1200/JCO.2015.65.4277. Epub 2016 Mar 21. PubMed PMID: 27001585.
• Demirci U, Dızdar O, Cetindag MF, Altınova S, Ozsavran A, Dede DS, Kızılırmak N, Eraslan FA, Yalcın B, Cinkir HY. Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer. J Cancer Res Ther. 2015 Oct-Dec;11(4):704-7. doi: 10.4103/0973-1482.147381. PubMed PMID: 26881505.
• Dizdar O, Arslan C, Altundag K. Advances in PARP inhibitors for the treatment of breast cancer. Expert Opin Pharmacother. 2015;16(18):2751-8. doi: 10.1517/14656566.2015.1100168. Epub 2015 Oct 20. Review. PubMed PMID: 26485111.
• Dizdar O. Is dexamethasone a better partner for abiraterone than prednisolone? Oncologist. 2015 May;20(5):e13. doi: 10.1634/theoncologist.2014-0472. Epub 2015 Apr 17. PubMed PMID: 25888271; PubMed Central PMCID: PMC4425392.
• Aksoy DY, Durusu Tanriover M, Unal S, Dizdar O, Kalyoncu U, Karakaya J, Unal S, Kale G. Burnout syndrome during residency in internal medicine and pediatrics in a country without working time directive. Int J Health Care Qual Assur. 2014;27(3):223-30. doi: 10.1108/IJHCQA-12-2012-0127. PubMed PMID: 25786186.
• Arslan C, Dizdar O, Altundag K. Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update. Expert Opin Pharmacother. 2014 Aug;15(12):1643-58. doi: 10.1517/14656566.2014.929664. Review. PubMed PMID: 25032884.
• Rahatli S, Dizdar O, Kucukoztas N, Oguz A, Yalcin S, Ozen O, Reyhan NH, Tarhan C, Yildiz F, Dursun P, Altundag O, Ayhan A. Good outcomes of patients with stage IB endometrial cancer with surgery alone. Asian Pac J Cancer Prev. 2014;15(9):3891-3. PubMed PMID: 24935569.
• Tuna S, Dizdar O, Calis M. The prevalence of usage of herbal medicines among cancer patients. J BUON. 2013 Oct-Dec;18(4):1048-51. PubMed PMID: 24344037.
• Ozcan MF, Dizdar O, Dincer N, Balcı S, Guler G, Gok B, Pektas G, Seker MM, Aksoy S, Arslan C, Yalcin S, Balbay MD. Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy. Urol Oncol. 2013 Nov;31(8):1709-15. doi: 10.1016/j.urolonc.2012.06.014. Epub 2012 Aug 3. PubMed PMID: 22863869.

Gaye Güler Tezel

• Şahlı E, Hoşal BM, Zilelioğlu G, Dinçer N, Tezel GG. The role of apoptosis in blepharoptosis. Eye (Lond). 2013 Jul;27(7):823-7. doi: 10.1038/eye.2013.73. Epub 2013 Apr 19.
• Guney G, Tezel GG, Kosemehmetoglu K, Yilmaz E, Balci S, Ersoy R, Cakir B, Guler G. Molecular Features of Follicular Variant Papillary Carcinoma of Thyroid: Comparison of Areas With or Without Classical Nuclear Features.Endocr Pathol. Endocr Pathol. 2014 Sep;25(3):241-7. doi: 10.1007/s12022-013-9275-6.
• Akkapulu N, Tirnaksiz MB, Kulac I, Tezel GG, Hayran M, Dogrul AB, Cetinkaya E, Yorganci K. Effects of intra-abdominal pressure on adrenal gland function and morphology in rats. Int J Clin Exp Pathol. 2015 Mar 1;8(3):3230-7. 
• LInke ES, Tezel GG. Application of Molecular Pathology in Endocrine Pathology. Turk Patoloji Derg. 2015;31 Suppl 1:181-188. doi: 10.5146/tjpath.2015.01324.
• Kartal K, Onder S, Kosemehmetoglu K, Kilickap S, Tezel YG, Kaynaroglu V. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material. BMC Cancer. 2015 Oct 30;15(1):824. doi: 10.1186/s12885-015-1861-1. 
• Irkkan C, Balci S, Güler Tezel G, Akinci B, Yalcin B, Güler G. Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers. Appl Immunohistochem Mol Morphol. 2016 Mar 3. [Epub ahead of print]
• Aydin K, Aydin C, Dagdelen S, Tezel GG, Erbas T. Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly. Exp Clin Endocrinol Diabetes. 2016 Mar;124(3):198-202. doi: 10.1055/s-0035-1565061. Epub 2015 Nov 17.
• Onerci Celebi O, Tezel GG, Hosal AS, Cengiz M, Gullu IH, Hayran M. Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer. Pathol Res Pract. 2016 May;212(5):456-62. doi: 10.1016/j.prp.2016.02.022. Epub 2016 Feb 26.
• Tatlı Doğan H, Kılıçarslan A, Doğan M, Süngü N, Güler Tezel G, Güler G. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients. Pathol Res Pract. 2016 Nov;212(11):1021-1026. doi: 10.1016/j.prp.2016.08.013.
• Cigdem Ussakli, Alp Usubutun, Nazmiye Dincer, Anil Dolgun, Diilek Bülbül, Zuhal Isikdogan, Nihan Haberal, Ozlem Ozen, Gaye Guler Tezel. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation. Pol J Pathol 2016; 67 (3): 221-227. doi: 10.5114/pjp.2016.63773.
• Sener E, Yildirim P, Tan A, Gokoz O, Tezel GG. Investigation of BRAF mutation analysis with different technical platforms in metastatic melanoma. Pathol Res Pract. 2017 Jan 21. pii: S0344-0338(16)30822-6. doi: 10.1016/j.prp.2017.01.010. [Epub ahead of print] PMID:28216139
• Rekhi B, Kosemehmetoglu K, Tezel GG, Dervisoglu S. Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis.APMIS. 2017 Apr 27. doi: 10.1111/apm.12702. [Epub ahead of print] PMID: 28452074
• Güler Tezel G, Şener E, Aydın Ç, Önder S. Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population. Balkan Med J. 2017 Dec 1;34(6):567-571. doi: 10.4274/balkanmedj.2017.0297. Epub 2017 Aug 23.
• Kösemehmetoğlu K, Özoğul E, Babaoğlu B, Tezel GG, Gedikoğlu G. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.Turk Patoloji Derg. 2017;1(1):192-197. doi: 10.5146/tjpath.2017.01395.

Ayşegül Üner

• Kiratli H, Tarlan B, Uzun S, Tanas Ö, Uner A, ‘Orbital richter syndrome’, Orbit. 32(6):381-3, 2013.
• Saglam A, Akyurek N, Soylemezoglu F, Uner A, ‘Epstein-Barr virus frequency in primary central nervous system lymphomas in Turkey’APMIS. 121(3):232-8, 2013.
• Koca, E., Cetiner, D.A., Buyukasik, Y., Uner, A., Sayinalp, N., Haznedaroglu, I.C., Goker, H., Aksu, S., Ozcebe, O.I., ‘Bone marrow iron staining is a reliable test for elimination of iron deficiency anemia rather than its diagnosis’, Uluslararası Hematoloji-Onkoloji Dergisi 23 (4):260, 2013
• Demir HA, Bayhan T, Üner A, Kurtulan O, Karakuş E, Emir S, Özyörük D, Ceylaner S. ‘Chronic lymphocytic leukemia in a child: a challenging diagnosis in pediatric oncology practice’ Pediatr Blood Cancer. 2014 61(5):933-5, 2014.
• Kiratli H, Tarlan B, Tanas O, Uner A. ‘Bilateral orbital involvement as the presenting sign of chronic lymphocytic leukemia’ .See comment in PubMed Commons belowJ Fr Ophtalmol. 37(1):e9-e10, 2014.
• Koydemir, H.C., Kulah, H., Alp, A., Uner, A.H., Hascelik, G., Ozgen, C. ‘A fully microfabricated electrochemical sensor and its implementation for detection of methicillin resistance in Staphylococcus aureus’, IEEE Sensors Journal 14 (6) , pp. 1844, 2014.
• Köybaşı S, Seyhan S, Biçer YÖ, Üner A, Yeşilırmak A, ‘Nasal type natural killer T-cell lymphoma involving nasooropharynx and larynx’, Kulak Burun Bogaz Ihtis Derg. Nov-Dec;24(6):364-7, 2014.
• Kocabeyoglu S, Mocan MC, Haznedaroglu IC, Uner A, Uzunosmanoglu E, Irkec M, ‘In vivo confocal microscopic characteristics of crystalline keratopathy in patients with monoclonal gammopathy: report of two cases’, Indian J Ophthalmol. 62(9):938-40, 2014.
• Kertmen N, Aksoy S, Uner A, Sargon M, Ozkayar O, Keskin O, Babacan T, Sarici F, Sendur MA, Arik Z, Akin S, Altundag K. ‘Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in rats’Anticancer Res. 35(2):857-64, 2015.
• Bektas O, Uner A, Aydin SM, Eliacik E, Uz B, Işık A, Haznedaroğlu IC, Goker H, Sayinalp N, Aksu S, Demiroglu H, Ozcebe OI, Buyukasik Y. ‘.High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology’, Int J Hematol. 102(2):211-7, 2015.
• Bektas O, Uner A, Buyukasik Y, Uz B, Bozkurt S, Eliacik E, Işik A, Haznedaroglu IC, Goker H, Demiroglu H, Aksu S, Ozcebe OI, Sayinalp N, ‘Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromes.’APMIS.;123(5):445-51, 2015.
• Eliaçık E, Isık A, Aydin C, Uner A, Aksu S, Sayinalp N, Demiroglu H, Goker H, Buyukasik Y, Ozcebe O, Haznedaroglu IC, ‘Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia.',Hematology;20(7):392-6. 2015
• Malkan UY, Gunes G, Yayar O, Demiroglu H, Yesilirmak A, Uner A., ‘A T-cell prolymphocytic leukemia case with central nervous system involvement’  Int J Clin Exp Med. 8(8):14207-9. eCollection 2015.
• Bektas O. Uner A, Eliacik E, Uz B, Işık A, Etgul S, Bozkurt S, Haznedaroğlu IC, Goker H, Sayinalp N, Aksu S, Demiroglu H, Ozcebe OI, Buyukasik Y. ‘Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems’, Turk J Haematol. 2015.
• Eliaçık E, Işık A, Aksu S, Üner A, Büyükaşık Y, Sayınalp N, Göker H, Özcebe OI, Haznedaroğlu İC, ‘Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms’ Turk J Haematol.;32(2):163-7, 2015.
• Yavas G, Gultekin M, Yildiz O, Seyrek M, Demirkol S, Toy H, Sargon MF, Ozkayar O, Uner A, Yildiz F, Akyol F., Assessment of concomitant versus sequential trastuzumab on radiation-induced cardiovascular toxicity. Hum Exp Toxicol. 2016 [Epub ahead of print]
• Kulaç İ, Demir Ç, Büyükaşık Y, Kutluk T, Üner A.’TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases.’Turk J Haematol.;34(1):34-39, 2017
• Sevmis M, Yoyen-Ermis D, Aydin C, Bilgic E, Korkusuz P, Uner A, Hamaloglu E, Esendagli G, Karakoc D., ‘Splenectomy-Induced Leukocytosis Promotes Intratumoral Accumulation of Myeloid-Derived Suppressor Cells, Angiogenesis and Metastasis’, Immunol Invest.;46(7):663-676, 2017
• Şimşek C, Bostankolu B, Özoğul E, Sağlam Ayhan A, Üner A, Büyükaşık Y. EBV-related Diffuse Large B-cell lymphoma in a Patient with Angioimmunoblastic T Cell Lymphoma: A Case Presentation., Turk J Haematol. 2018
• Yoyen-Ermis D, Ozturk-Atar K, Kursunel MA, Aydin C, Ozkazanc D, Gurbuz MU, Uner A, Tulu M, Calis S, Esendagli G. Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody.Mol Pharm.;15(4):1526-1533, 2018 
• Esendagli G, Yoyen-Ermis D, Guseinov E, Aras C, Aydin C, Uner A, Hamaloglu E, Karakoc D. Impact of repeated abdominal surgery on wound healing and myeloid cell dynamics., J Surg Res.; 223:188-197, 2018
• Mishra RR, Belder N, Ansari SA, Kayhan M, Bal H, Raza U, Ersan PG, Tokat ÜM, Eyüpoğlu E, Saatci Ö, Jandaghi P, Wiemann S, Üner A, Cekic C, Riazalhosseini Y, Şahin Ö. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer. Clin Cancer Res.;24(8):1987-2001, 2018.
• Saglam A, Balaban S, Yıldırım T, Erdem Y, Uner A, Büyükaşık Y. Monoclonal gammopathy of renal significance presenting as monotypic plasma cell interstitial nephritis in two patients with Sjögren's syndrome., Virchows Arch.;472(5):865-869, 2018